Corten Capital and Ampersand Capital Partners (“Ampersand”) are pleased to announce the completion of their acquisition of Beacon Intelligence (“Beacon” or the “Company”) from the Hanson Wade Group, backed by Graphite Capital. Ampersand is investing alongside Corten as a minority co-investor in the transaction. Beacon was founded in 2015 within the Hanson Wade Group, an Events and Conferences operator focused on the life sciences industry, to address a critical gap in structured, granular data on early-stage drug development. The Beacon platform is now used daily by over 300 customers globally, including 24 of the 30 largest global pharmaceutical companies.
Read the full article: Corten and Ampersand Complete Acquisition of Beacon Intelligence to Accelerate Growth in Life Sciences R&D Intelligence //
Source: https://www.cortencapital.com/beacon-intelligence-acquisition-completion.html